Publications by authors named "Yufei Bi"

Claim this Profile
A
Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression.
Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Bingbing Zhu, Yufei Bi

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progranulin mediates the onset of pristane induced systemic lupus erythematosus.
Michun He, Aubryanna Hettinghouse, Yufei Bi, Yuehong Chen, Chuanju Liu

Adv Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of High-Density Lipoprotein Cholesterol in Patients with Overt Hepatic Encephalopathy.
Ke Shi, Yufei Bi, Xiaojing Wang, Yanqiu Li, Xuanwei Zeng

Biomedicines· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Na1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis.
Wenyu Fu, Dmytro Vasylyev, Yufei Bi, Mingshuang Zhang, Guodong Sun

Nature· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis.
Jia-Liang Chen, Yao Liu, Yu-Fei Bi, Xian-Bo Wang

World J Gastroenterol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Fengna Yan, Qun Zhang, Ke Shi, Yi Zhang, Bingbing Zhu, Yufei Bi

Front Cell Infect Microbiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma.
Ke Shi, Jie Hou, Qun Zhang, Yufei Bi, Xuanwei Zeng

Front Nutr· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma.
Ke Shi, Yufei Bi, Xuanwei Zeng, Xianbo Wang

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis.
Yufei Bi, Ke Shi, Jialiang Chen, Xianbo Wang

Front Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis.
Qun Zhang, Shuaishuai Niu, Li Yang, Bingbing Zhu, Ke Shi, Yufei Bi

Front Cell Infect Microbiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals.
Ke Shi, Ping Li, Qun Zhang, Yi Zhang, Yufei Bi

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis.
Ke Shi, Qun Zhang, Yi Zhang, Yufei Bi, Xuanwei Zeng

Front Cell Infect Microbiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic nomogram to predict transplant-free mortality in patients with hepatitis B-related cirrhosis and overt hepatic encephalopathy.
Ke Shi, Yunyi Huang, Qun Zhang, Chongping Ran, Jie Hou, Yufei Bi

Int Immunopharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of LiangXue JieDu Therapy in Combination With Western Medicine for Acute-On-Chronic Liver Failure: A Systematic Review and meta-Analysis.
Ke Shi, Qun Zhang, Jie Hou, Yi Zhang, Yufei Bi

Front Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sugar-Sweeten Beverage Consumption Is Associated With More Obesity and Higher Serum Uric Acid in Chinese Male Gout Patients With Early Onset.
Qian-Hua Li, Yao-Wei Zou, Shu-Yan Lian, Jin-Jian Liang, Yu-Fei Bi

Front Nutr· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.
Wenyu Fu, Wenhuo Hu, Young-Su Yi, Aubryanna Hettinghouse, Guodong Sun, Yufei Bi

J Clin Invest· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis.
Ronghan Liu, Yuehong Chen, Wenyu Fu, Shuya Wang, Yazhou Cui, Yufei Bi

Ann Rheum Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis